definiens: shall mean any technical information furnished by one Party ( the ) to the other Party ( the ) in connection with this Agreement . Such Confidential Information mayinclude, without limitation, the identity, nucleotide sequence, or structure of an ImmunomodulatoryOligodeoxynucleotide, the applicability or use of any Immunomodulatory Oligodeoxynucleotide for a particularoncology indication, information relating to the mechanism of immune stimulation for a particular ImmunomodulatoryOligodeoxynucleotide, information about the composition of, or modifications to the nucleotides or backbone, as wellas any product specifications, trade secrets, know - how, inventions, intellectual property, technical data orspecifications, discovery methods, screening assays or other testing methods, research and development activitiesand data and information developed in the course of activities pursuant to this Agreement, Screening Committeereports, and the Plan . In the case of information supplied in writing, the Disclosing Party will mark it . Inthe case of information first supplied orally, the Disclosing Party will outline it in a written summary declaring it to beconfidential and delivering such summary to the Receiving Party within 30 days of the original disclosure